Research in Pharmaceutical Biotechnology

  • Abbreviation: Res. Pharm. Biotech.
  • Language: English
  • ISSN: 2141-2324
  • DOI: 10.5897/RPB
  • Start Year: 2009
  • Published Articles: 43

About RPB

Research in Pharmaceutical Biotechnology (RPB) is a peer reviewed open access journal. The journal is published monthly and covers all areas of the subject such as bioengineering, biomimetics, tissue culture, drug design and development.
 
Research in Pharmaceutical Biotechnology is indexed in Chemical Abstracts (CAS Source Index)
 
 
Open Access is a publication model that enables the dissemination of research articles to the global community without restriction through the internet. All articles published under open access can be accessed by anyone with internet connection.

The Research in Pharmaceutical Biotechnology is an Open Access journal. Abstracts and full texts of all articles published in this journal are freely accessible to everyone immediately after publication without any form of restriction.
 
All articles published by Research in Pharmaceutical Biotechnology are licensed under the Creative Commons Attribution 4.0 International License. This permits anyone to copy, redistribute, remix, transmit and adapt the work provided the original work and source is appropriately cited. Citation should include the article DOI. The article license is displayed on the abstract page the following statement:
 
This article is published under the terms of the Creative Commons Attribution License 4.0
 
When an article is published by in the Research in Pharmaceutical Biotechnology, the author(s) of the article retain the copyright of article. Author(s) may republish the article as part of a book or other materials. When reusing a published article, author(s) should;

Cite the original source of the publication when reusing the article. i.e. cite that the article was originally published in the Research in Pharmaceutical Biotechnology. Include the article DOI
Accept that the article remains published by Research in Pharmaceutical Biotechnology (except in occasion of a retraction of the article)
The article is licensed under the Creative Commons Attribution 4.0 International License.

A copyright statement is stated in the abstract page of each article. The following statement is an example of a copyright statement on an abstract page.
Copyright ©2016 Author(s) retains the copyright of this article.
 
The Research in Pharmaceutical Biotechnology is a RoMEO green journal. This permits authors to archive any version of their article they find most suitable, including the published version on their institutional repository and any other suitable website.
 
The Research in Pharmaceutical Biotechnology is committed to the long-term preservation of its content. All articles published by the journal are preserved by Portico. In addition, the journal encourages authors to archive the published version of their articles on their institutional repositories and as well as other appropriate websites.
 
The Research in Pharmaceutical Biotechnology encourages metadata harvesting of all its content. The journal fully supports and implement the OAI version 2.0, which comes in a standard XML format. See Harvesting Parameter
 
Article metrics is increasingly an important measure of the impact of a published article. The journal provides article metrics for each published article. The article metrics provides a record of the number of views received by the article. It also keeps a record of the full text PDF downloads. Article metrics is available on the abstract page of each article.

Manuscript Handling Fee
Authors are required to pay the manuscript handling fee only after their manuscripts have been reviewed and accepted for publication by an editor.
 
The manuscript handling fee for RPB is $650 (USD).
 
Please note that the journal does not charge a submission fee  
 
Waiver Policy
The journal may grant partial waivers to some categories of authors. Kindly see Waiver Policy if you are eligible for a waiver.
 
Editorial Office: [email protected]
Ethics & Compliance  [email protected]
Helpdesk: [email protected]